BioCentury
ARTICLE | Clinical News

Carbavance: Phase III started

November 17, 2014 8:00 AM UTC

The Medicines Co. began the double-blind U.S. Phase III TANGO 1 trial to compare thrice-daily 2 g/2 g IV Carbavance vs. IV Zosyn tazobactam/piperacillin in about 850 adults with cUTIs or acute pyelo...